9 analysts have shared their evaluations of Celanese CE during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 6 | 1 | 1 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 4 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 0 | 0 |
3M Ago | 1 | 1 | 0 | 1 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $168.44, along with a high estimate of $195.00 and a low estimate of $135.00. This upward trend is apparent, with the current average reflecting a 9.73% increase from the previous average price target of $153.50.
Interpreting Analyst Ratings: A Closer Look
The perception of Celanese by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Michael Sison | Wells Fargo | Raises | Overweight | $195.00 | $180.00 |
Arun Viswanathan | RBC Capital | Lowers | Outperform | $165.00 | $168.00 |
Charles Neivert | Piper Sandler | Raises | Overweight | $170.00 | $135.00 |
Ghansham Panjabi | Baird | Raises | Outperform | $165.00 | $135.00 |
Michael Sison | Wells Fargo | Raises | Overweight | $180.00 | $167.00 |
Hassan Ahmed | Alembic Global | Announces | Neutral | $160.00 | - |
Steve Byrne | B of A Securities | Raises | Underperform | $135.00 | $124.00 |
Joshua Spector | UBS | Raises | Buy | $170.00 | $169.00 |
Aleksey Yefremov | Keybanc | Raises | Overweight | $176.00 | $150.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Celanese. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Celanese's stock. This examination reveals shifts in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Celanese analyst ratings.
Unveiling the Story Behind Celanese
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Financial Insights: Celanese
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Celanese's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 9.41%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Celanese's net margin excels beyond industry benchmarks, reaching 27.17%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Celanese's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.28% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Celanese's ROA excels beyond industry benchmarks, reaching 2.68%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.99, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
What Are Analyst Ratings?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.